RxDoctor Payments Data

Mieasha Barksdale

Foot & Ankle Surgery · Greenfield, INNPI 1740547769

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by New Standard Device, LLC Dba Metalogix at 28.1% of the total. Reporting peaked in 2022 at $10,519 and has fallen 97.0% since, to $315 in 2025.

$20,401in general payments, 2019–2025

Across 146 payments — averaging $139.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • New Standard Device, LLC Dba Metalogix$6K
  • Skye Orthobiologics LLC$3K
  • Ortho Solutions Inc$2K
  • Summ Cott Medical$2K
  • Stryker$2K
  • Flower Orthopedics Coporation$1K
  • plus $4K from 26 others
$25,500in research payments, 2019–2025

Across 3 payments — averaging $8500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Skye Orthobiologics LLC$26K

What the payments were for

  • Consulting fees$11,67557%
  • Speaking & faculty fees$3,00015%
  • Travel & lodging$1,96810%
  • Food & beverage$3,75718%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,401 in reported general payments places this provider in the 85th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$143,662
Medicare patients
278
Services billed
1,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate114$1,678
Methylprednisolone98$610
Meloxicam153$335
Cephalexin37$320
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$153

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Greenfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →